ES2171911T3 - Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos. - Google Patents

Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.

Info

Publication number
ES2171911T3
ES2171911T3 ES97911695T ES97911695T ES2171911T3 ES 2171911 T3 ES2171911 T3 ES 2171911T3 ES 97911695 T ES97911695 T ES 97911695T ES 97911695 T ES97911695 T ES 97911695T ES 2171911 T3 ES2171911 T3 ES 2171911T3
Authority
ES
Spain
Prior art keywords
polyamins
independently
compounds
conformationally restricted
cicloarilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97911695T
Other languages
English (en)
Inventor
Benjamin J Frydman
Laurence J Marton
Vendohar K Reddy
Aldonia L Valasinas
Donald T Witiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2171911T3 publication Critical patent/ES2171911T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/18—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/22—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing at least two amino groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I): E NH - D NH - B - A - B - NH - D - NH - E, DONDE A ES ALQUENO C SUB,2 C 6 , CICLOALQUILO C 3 - C 6 , CICLOALQUEN ILO O CICLOARILO; B ES INDEPENDIENTEMENTE UN ENLACE SIMPLE, ALQUILALQUENILO C 1 - C 6 ; D ES INDEPENDIENTEMENTE ALQ UILO O ALQUENILO C 1 - C 6 , O CICLOALQUILO C 3 - C 6 , CICLOALQUENILO O CICLOARILO; Y E ES INDEPENDIENTEMENTE H, ALQUILO C 1 - C 6 O ALQUENILO. SE INCLUYEN A SIMISMO LAS SALES FARMACEUTICAMENTE ACEPTABLES DE DICHOS COMPUESTOS, UN PROCEDIMIENTO DE SINTESIS DE LOS MISMOS, FORMAS DE ADMINISTRACION FARMACEUTICAS QUE INCLUYEN UNO O MAS DE DICHOS COMPUESTOS, Y LA UTILIZACION DE LOS MISMOS EN EL TRATAMIENTO DE LA PROLIFERACION CELULAR NEOPLASICA.
ES97911695T 1996-10-18 1997-10-15 Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos. Expired - Lifetime ES2171911T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2868096P 1996-10-18 1996-10-18

Publications (1)

Publication Number Publication Date
ES2171911T3 true ES2171911T3 (es) 2002-09-16

Family

ID=21844851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97911695T Expired - Lifetime ES2171911T3 (es) 1996-10-18 1997-10-15 Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.

Country Status (6)

Country Link
EP (1) EP0934249B1 (es)
JP (2) JP3891496B2 (es)
AU (1) AU4900797A (es)
DE (1) DE69711413T2 (es)
ES (1) ES2171911T3 (es)
WO (1) WO1998017624A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
WO2000066587A2 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Polyamines and their use in therapy
MXPA01011008A (es) * 1999-04-30 2003-06-30 Slil Biomedical Corp Conjugados analogos de poliamina y conjugados de quinona novedosos como terapia para canceres y enfermedades de la prostata.
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
WO2002091989A2 (en) 2000-11-08 2002-11-21 Slil Biomedical Corporation Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
WO2003033455A1 (en) 2001-10-16 2003-04-24 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
US6982351B2 (en) 2001-12-07 2006-01-03 Cellgate, Inc. Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
MXPA04007584A (es) 2002-02-07 2004-12-06 Wisconsin Alumni Res Found Compuestos de poliamina y composiciones para su uso en conjunto con una terapia contra el cancer.
WO2005014524A2 (en) 2003-08-07 2005-02-17 Wisconsin Alumni Research Foundation Amino thiol compounds and compositions for use in conjunction with cancer therapy
EP1940773B1 (en) 2005-08-10 2015-03-18 Johns Hopkins University Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
EP1937235B1 (en) 2005-09-23 2015-07-01 Pathologica, LLC. Methods for treating viral infections using polyamine analogs
WO2012009475A1 (en) * 2010-07-14 2012-01-19 Oregon Health & Science University Methods of treating cancer with inhibition of lysine-specific demethylase 1
CN102212013A (zh) * 2011-03-30 2011-10-12 广东中科药物研究有限公司 一种多胺化合物及其制备方法和应用
US9567316B2 (en) 2012-03-07 2017-02-14 The Mclean Hospital Corporation Aminoquinoline derivatives and uses thereof
CN104072624B (zh) * 2014-05-15 2016-05-18 温州医科大学 一种多胺改性高分子药物及其制备方法与作为抗肿瘤药物的应用
CN109651235B (zh) * 2018-12-13 2020-09-22 天津利安隆新材料股份有限公司 一种尼龙助剂的制备方法
WO2021108632A1 (en) 2019-11-25 2021-06-03 The General Hospital Corporation Methods and compositions for enzymatic polymerization of n3' -> p5' phosphoramidate dna

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
CA1305425C (en) * 1986-12-02 1992-07-21 Raymond J. Bergeron Anti-neoplastic spermine derivative
BR9405892A (pt) * 1993-12-27 1995-12-12 Ciba Geigy Ag Compostos de amino insaturados para uso como agente anti-câncer e anti-protozoários

Also Published As

Publication number Publication date
DE69711413D1 (de) 2002-05-02
JP2002508739A (ja) 2002-03-19
DE69711413T2 (de) 2002-07-18
AU4900797A (en) 1998-05-15
JP3891496B2 (ja) 2007-03-14
JP2005255690A (ja) 2005-09-22
EP0934249B1 (en) 2002-03-27
EP0934249A1 (en) 1999-08-11
WO1998017624A1 (en) 1998-04-30
JP4322842B2 (ja) 2009-09-02

Similar Documents

Publication Publication Date Title
ES2159738T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
ES2122043T3 (es) Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
ECSP941122A (es) Derivados de 5-arilindoles
ES2153907T3 (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y su uso como antagonistas del receptor 5ht1d.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
PA8546601A1 (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
IS2176B (is) 2-oxó-1-pýrrólidín afleiður, aðferðir til framleiðslu á þeim og notkun þeirra
ES2145254T3 (es) Formulaciones de aerosoles que contienen flunisolida.
UY27456A1 (es) Derivados de 1,6-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
PA8547901A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
SV1998000029A (es) Compuestos de pirazina ref. pg3186
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
ES2165986T3 (es) 3-cilindoles como agonistas del receptor cb2.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9301197A (es) Derivados de indol.
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
ES2110260T3 (es) Androstenonas.
UY27232A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos
ES2147427T3 (es) Aminas ciclicas n-sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 934249

Country of ref document: ES